Kadıpaşaoğlu A. K. (Executive), Türker T., Meşe E.
TUBITAK Project, 1003 - Priority Areas R&D Projects Support Program, 2019 - 2024
|
Although
the only non-palliative therapy for end-stage heart failure is heart
transplantation, the donor-recipient mismatch severely limits the effective
application of the procedure. Mechanical Circulatory Support (MCS) Systems,
which started to be developed since the early 60’s, are being used
increasingly more often as bridge-to-transplant or as destination therapy in
this cohort of patients in Turkey and worldwide. Today these systems, which
consist of a blood pump unloading the left ventricle, an actuator that
imparts energy to the pump, a pneummatic or electromechanic power source, a
control unit, and accessories such as grafts, connectors, cables, have been
miniaturized and converted into portable, totally implantable,
robust, dependable and smart technologies. In Turkey, as in most
developing countries, development of competitive MCS systems locally is a
medical, humanitarian need, as well as a scientific, technological and
economic necessity. This project is being submitted in an attempt to develop
an innovative MCS system as a national and original solution to this problem.
A single-stage axial turbine and a brushless DC motor actuating the turbine’s
rotor will constitute the Sub-Components (SC) of the Left Ventricular Assist
Device (LVAD), which is the first Basic Technological Component (BTC1) of the
proposed System. The original geometry of the turbine, developed in
preliminary studies, will be optimized numerically (Computational Fluid
Dynamics, CFD) and manufactured on a 3-D printer out of Ti6Al4V in the initial
phase of the Main Project. Prior to being integrated with the motor,
the flow fields and shear stress areas over the rotor and stator blades will
be visualized using optical techniques (Particle Image Velocimetry, PIV), as
the turbine will be connected to a hydraulic circuit and actuated on the
External Driving Mechanism. The solid model will be optimized until CFD-PIV
iterations converge. As part of the Sub-Project 1, and simultaneously
with the Main Project, the motor will be developed using low-conductance
Titanium alloy and high energy-density magnets. Parasitic Titanium losses and
magnet losses willl be minimized with the innovative application of material segmentation, while system efficiency will
be increased by encapsulating the stator, thus rendering the blood-contacting
surfaces of the air gap less porous. The two Sub-Components of the System
Control Unit (BTC2), which will be developed under Sub-Project 2, will
be the Ergonomic Patient Interface and the Two-Way Data Communication
Protocol. The Protocol will stream real-time values of important physiologic
and electeomechanic variables to the patient interface and to the nursing (or
monitoring) station (encrypted); and also, originally, allow for remote
professional intervention should a medical emergency arise. The Controller embedded in the Control Unit
is the third component of the Unit, and will be developed as part of the Main
Project. The Controller will have a superior design incorporating a
non-linear adaptive backstepping control algorithm, which allows stable and
robust control of the turbine speed while, concurrently, avoiding adverse
events such as hemolysis or ventricular suction caused by excessive speeds,
or pump thrombosis or tissue ischemia caused by speeds too low. The System, its Basic Technological
Components, and their Sub-Components will be verified and validated in the
operational environment provided by an advanced cardiovascular Mock Circuit,
capable of simulating with high accuracy normal resting and exercise
conditions. The Circuit will constitute the third BTC of the project, and
will be developed as part of the Main Project. It will operate based
on the Pontryagin Maximum Principle (PMP) so as to determine the time-varying
elastance (pressure-volume relationship) of the left ventricle, which
maximizes left ventricular hydraulic efficiency on a beat-to-beat basis. The
fact that left ventricular function will be derived analytically using one of
the most powerful techniques of Optimal Control Theory, rather than through
an empirical elastance formula fed as an input into the system as is done in
the literature to-date, is expected to offer an effective, applicable and
original platform for testing LVAD performance. The Principle Investigator of the
present proposal has close
to twenty years of research and administrative experience at the Texas Heart
Institute (THI) in Houston, TX, one of the most advanced MCS centers in the
world. During that time, he has actively participated in the design, testing
and experimental and clinial trial stages of most MCS systems in the world,
among them HeartMate-II and HeartWare. The
Surgical Consultant of the project, Dr. M. Hakan Akay, has been trained in
the THI Heart Transplant, Heart Failure and MCS services of Drs. Denton A.
Cooley and Bud H. Fraizer, two of the most experienced and highly respected
cardiac surgeons in the world. He is currently the Surgical Director of the
Advanced Heart Failure Center of Memorial Hermann Hospital in Houston, TX. Professor
Erkan Meşe, Co-Investigator and Director of Sub-Project I in the current
proposal, is an internationally renowned expert in the field of Electrical
Machinery, and a scholar with many important scientific papers, inventions
and technical patents. Dr.
Türker Türker is a young, successful, dynamic and productive academician, who is beginning to make a
name for himself in the field Non-Linear Control. The
expertise and theoretical strength of the academic team, and the know-how and
field experience of the Industrial Partner are factors that combine to ensure
the success of the project,
which aims at arriving to the design-freeze phase (end of TRL6) of a robust
and dependable prototype ready for biological testing. Created by an able and
motivated team using 100% national resources, the technology is expected to
have a high medical, scientific, industrial and economical impact |
|
Keywords: Heart Failure, Mechanical Circulatory
Assistance, Left Ventricular Assist Device, Cardiovascular Simulation
Circuit, Time-varying Left Ventricular Elastance, Mechanical Circulatory
Assistance, Adaptive Backstepping Control, Brushless Motor Design,
Bidirectional Wireless Communication, Pontryagin Maximum Principle |